Celyad Oncology

Rue Edouard Belin 12

1435 Mont-Saint-Guibert

BE

Celyad Oncology

Foundation date

24 July 2007

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Celyad Oncology is a biotechnology company focused on the discovery and development of CAR T therapies for cancer. The Company is developing a pipeline of allogeneic (off-the-shelf) and autologous (personalized) CAR T cell therapy candidates for the treatment of both hematological malignancies and solid tumors. Celyad Oncology was founded in 2007 and is based in Mont-Saint-Guibert, Belgium. For more information, please visit www.celyad.com.

Latest news

  • Antonin (Tony) de Fougerolles appointed as new Chair of etherna

    Tuesday July 16th 2024

  • ONTOFORCE Achieves ISO 27001:2022 Certification: A Milestone in Information Security and Trust

    Tuesday July 16th 2024

  • Ghent University spin-off Trince wins Nature Spinoff Prize

    Monday July 15th 2024